Developing affordable cancer detection technologies for underserved communities
The Center for Innovation and Translation of Point of Care Technologies for Equitable Cancer Care (CITEC)
This study is working on new, easy-to-use tools that can help find cancer early, especially for people who might not have easy access to healthcare, so that everyone can get the care they need.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Rice University NIH-funded |
| Lab location | 1 site (Houston, United States) |
| Project ID | NIH-10928771 on NIH RePORTER |
What this research studies
This research focuses on creating point-of-care technologies that can detect cancer early, especially in underserved populations. It aims to identify critical clinical needs and accelerate the development of effective and affordable cancer detection methods. The project will also evaluate the impact of these technologies in various healthcare settings and provide training for developers and healthcare providers to ensure equitable access. By addressing the barriers to early cancer detection, this initiative seeks to improve health outcomes for diverse communities.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals from racial and ethnic minorities and other medically underserved communities who are at risk for various types of cancer.
Not a fit: Patients who are not part of underserved populations or those who do not have access to primary care services may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more accessible and effective cancer detection methods, ultimately reducing cancer-related deaths in underserved populations.
How similar studies have performed: Previous research has shown success in developing point-of-care technologies for other health conditions, indicating potential for similar advancements in cancer detection.
Where this research is happening
Houston, United States
- Rice University — Houston, United States (Active)
Researchers
- Principal investigator: Richards-Kortum, Rebecca R. — Rice University
- Study coordinator: Richards-Kortum, Rebecca R.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.